Petroleo Brasileiro SA Petrobras
PBR
Oracle
ORCL
Ecopetrol
EC
Vale SA
VALE
Coinbase
COIN
US Stock MarketDetailed Quotes
SABS SAB Biotherapeutics
- 1.6600
- +0.0500+3.11%
Trading Mar 17 12:08 ET
15.32MMarket Cap-0.26P/E (TTM)
1.8700High1.5300Low12.70KVolume1.6000Open1.6100Pre Close20.82KTurnover0.19%Turnover RatioLossP/E (Static)9.23MShares5.010052wk High0.42P/B11.18MFloat Cap1.450052wk Low--Dividend TTM6.73MShs Float129.0000Historical High--Div YieldTTM21.12%Amplitude1.4500Historical Low1.6380Avg Price1Lot Size
About SAB Biotherapeutics Company
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
Company Profile
SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address777 West 41st Street,Suite 401
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33140
Phone1-605-679-6980
Websitehttp://www.sab.bio
Company Executives
- Name
- Position
- Salary
- Samuel J. Reich
- Chief Executive Officer and Director
- 565.80K
- Dr. Alexandra Kropotova, M.D.
- Chief Medical Officer and Executive Vice President
- 921.58K
- Lucy To
- Chief Financial Officer
- --
- Christoph Lawrence Bausch
- Chief Operating Officer
- 549.32K
- Mark William Conley, C.P.A.
- Vice President, Finance
- --
- Dr. Eddie J. Sullivan, PhD
- Director and President
- 202.60K
- David Link, M.B.A.
- Vice Chairman of the Board
- 25.00K
- Dr. Jay S. Skyler,M.D.,M.A.C.P.
- Director
- --
- Helen Katherine Ellias
- Independent Director
- --
- Christine Hamilton, M.B.A.
- Independent Director
- 25.00K
- Andrew D. Moin
- Independent Director
- --
- Jeffrey G. Spragens
- Independent Director
- 25.00K
- Erick J. Lucera, C.F.A.
- Independent Director
- 26.93K
- Dr. William J. Polvino, M.D.
- Independent Director
- 25.00K
- Admiral Scott Giberson, (Ret.)
- Independent Director
- 25.00K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.